A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Royal Prince Alfred Hospital, Camperdown

Peter MacCallum Cancer Center, Melbourne

Sir Charles Gairdner, Nedlands

MSKCC, New York

Montefiore Medical Center, The Bronx

University of Pennsylvania, Philadelphia

Emory, Atlanta

University of Minnesota, Minneapolis

University of Chicago, Chicago

Washington University Saint Louis, St Louis

University of Kansas, Westwood

UT Southwestern, Dallas

MD Anderson Cancer Center, Houston

Methodist Hospital-Sarah Cannon, San Antonio

University of Utah-Huntsman Cancer Institute, Salt Lake City

Cedars Sinai, Los Angeles

City of Hope, Duarte

Stanford, Stanford

Oregon Health and Science University, Portland

Yale New Haven Hospital, New Haven

Princess Margaret, Toronto

University Hospital Hamburg-Eppendorf, Hamburg